320 related articles for article (PubMed ID: 27488117)
1. IQGAP1 gene silencing induces apoptosis and decreases the invasive capacity of human hepatocellular carcinoma cells.
Zoheir KM; Abd-Rabou AA; Harisa GI; Kumar A; Ahmad SF; Ansari MA; Abd-Allah AR
Tumour Biol; 2016 Oct; 37(10):13927-13939. PubMed ID: 27488117
[TBL] [Abstract][Full Text] [Related]
2. Gene expression of IQGAPs and Ras families in an experimental mouse model for hepatocellular carcinoma: a mechanistic study of cancer progression.
Zoheir KM; Abd-Rabou AA; Harisa GI; Ashour AE; Ahmad SF; Attia SM; Bakheet SA; Abdel-Hamied HE; Abd-Allah AR; Kumar A
Int J Clin Exp Pathol; 2015; 8(8):8821-31. PubMed ID: 26464624
[TBL] [Abstract][Full Text] [Related]
3. Differential expression of IQGAP1/2 in Hepatocellular carcinoma and its relationship with clinical outcomes.
Xia FD; Wang ZL; Chen HX; Huang Y; Li JD; Wang ZM; Li XY
Asian Pac J Cancer Prev; 2014; 15(12):4951-6. PubMed ID: 24998570
[TBL] [Abstract][Full Text] [Related]
4. IQGAP1 and IQGAP2 are reciprocally altered in hepatocellular carcinoma.
White CD; Khurana H; Gnatenko DV; Li Z; Odze RD; Sacks DB; Schmidt VA
BMC Gastroenterol; 2010 Oct; 10():125. PubMed ID: 20977743
[TBL] [Abstract][Full Text] [Related]
5. Development of hepatocellular carcinoma in Iqgap2-deficient mice is IQGAP1 dependent.
Schmidt VA; Chiariello CS; Capilla E; Miller F; Bahou WF
Mol Cell Biol; 2008 Mar; 28(5):1489-502. PubMed ID: 18180285
[TBL] [Abstract][Full Text] [Related]
6. Hint1 suppresses migration and invasion of hepatocellular carcinoma cells in vitro by modulating girdin activity.
Wu XS; Bao TH; Ke Y; Sun DY; Shi ZT; Tang HR; Wang L
Tumour Biol; 2016 Nov; 37(11):14711-14719. PubMed ID: 27623945
[TBL] [Abstract][Full Text] [Related]
7. Overexpression of WWP1 promotes tumorigenesis and predicts unfavorable prognosis in patients with hepatocellular carcinoma.
Zhang XF; Chao J; Pan QZ; Pan K; Weng DS; Wang QJ; Zhao JJ; He J; Liu Q; Jiang SS; Chen CL; Zhang HX; Xia JC
Oncotarget; 2015 Dec; 6(38):40920-33. PubMed ID: 26506518
[TBL] [Abstract][Full Text] [Related]
8. Novel Approach Using shRNA of IQGAP1 for Colon Cancer Therapy: HCT116 as a Surrogate Model Colorectal Carcinoma.
Zoheir KMMA; Mahmoud K; Harisa GI; Ashour A; Abdel-Hamied HE; Amara AA; Mahrous KF; Abd-Rabou AA
Asian Pac J Cancer Prev; 2022 Jul; 23(7):2387-2395. PubMed ID: 35901346
[TBL] [Abstract][Full Text] [Related]
9. MicroRNA-137 represses FBI-1 to inhibit proliferation and in vitro invasion and migration of hepatocellular carcinoma cells.
Zhu M; Li M; Wang T; Linghu E; Wu B
Tumour Biol; 2016 Oct; 37(10):13995-14008. PubMed ID: 27492460
[TBL] [Abstract][Full Text] [Related]
10. FAM9C plays an anti-apoptotic role through activation of the PI3K/Akt pathway in human hepatocellular carcinoma.
Zhou JD; Shen F; Ji JS; Zheng K; Huang M; Wu JC
Oncol Rep; 2013 Sep; 30(3):1275-84. PubMed ID: 23836295
[TBL] [Abstract][Full Text] [Related]
11. Effect of PAK1 gene silencing on proliferation and apoptosis in hepatocellular carcinoma cell lines MHCC97-H and HepG2 and cells in xenograft tumor.
Zhang ZL; Liu GC; Peng L; Zhang C; Jia YM; Yang WH; Mao L
Gene Ther; 2018 Jul; 25(4):284-296. PubMed ID: 29802374
[TBL] [Abstract][Full Text] [Related]
12. IQGAP1 and IQGAP3 Serve Individually Essential Roles in Normal Epidermal Homeostasis and Tumor Progression.
Monteleon CL; McNeal A; Duperret EK; Oh SJ; Schapira E; Ridky TW
J Invest Dermatol; 2015 Sep; 135(9):2258-2265. PubMed ID: 25848980
[TBL] [Abstract][Full Text] [Related]
13. CSIG promotes hepatocellular carcinoma proliferation by activating c-MYC expression.
Cheng Q; Yuan F; Lu F; Zhang B; Chen T; Chen X; Cheng Y; Li N; Ma L; Tong T
Oncotarget; 2015 Mar; 6(7):4733-44. PubMed ID: 25749381
[TBL] [Abstract][Full Text] [Related]
14. β-Arrestin2 regulates lysophosphatidic acid-induced human breast tumor cell migration and invasion via Rap1 and IQGAP1.
Alemayehu M; Dragan M; Pape C; Siddiqui I; Sacks DB; Di Guglielmo GM; Babwah AV; Bhattacharya M
PLoS One; 2013; 8(2):e56174. PubMed ID: 23405264
[TBL] [Abstract][Full Text] [Related]
15. Knockdown of COBRA1 decreases the proliferation and migration of hepatocellular carcinoma cells.
El Zeneini E; Kamel S; El-Meteini M; Amleh A
Oncol Rep; 2017 Mar; 37(3):1896-1906. PubMed ID: 28112367
[TBL] [Abstract][Full Text] [Related]
16. RASSF10 is an epigenetically inactivated tumor suppressor and independent prognostic factor in hepatocellular carcinoma.
Wang F; Feng Y; Li P; Wang K; Feng L; Liu YF; Huang H; Guo YB; Mao QS; Xue WJ
Oncotarget; 2016 Jan; 7(4):4279-97. PubMed ID: 26701853
[TBL] [Abstract][Full Text] [Related]
17. MicroRNA-27b exerts an oncogenic function by targeting Fbxw7 in human hepatocellular carcinoma.
Sun XF; Sun JP; Hou HT; Li K; Liu X; Ge QX
Tumour Biol; 2016 Nov; 37(11):15325-15332. PubMed ID: 27704356
[TBL] [Abstract][Full Text] [Related]
18. HDAC inhibition activates the apoptosome via Apaf1 upregulation in hepatocellular carcinoma.
Buurman R; Sandbothe M; Schlegelberger B; Skawran B
Eur J Med Res; 2016 Jun; 21(1):26. PubMed ID: 27342975
[TBL] [Abstract][Full Text] [Related]
19. NKD1 correlates with a poor prognosis and inhibits cell proliferation by inducing p53 expression in hepatocellular carcinoma.
Zhang S; Li J; Wang X
Tumour Biol; 2016 Oct; 37(10):14059-14067. PubMed ID: 27507614
[TBL] [Abstract][Full Text] [Related]
20. IQGAP1 Is Involved in Enhanced Aggressive Behavior of Epithelial Ovarian Cancer Stem Cell-Like Cells During Differentiation.
Huang L; Xu S; Hu D; Lu W; Xie X; Cheng X
Int J Gynecol Cancer; 2015 May; 25(4):559-65. PubMed ID: 25675045
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
